{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:13:20Z","timestamp":1754108000890,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Division of Pharmacy, School of Medicine, University of Tasmania"},{"name":"School of Animal and Veterinary Sciences, Charles Sturt University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jpba.2018.02.048","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T13:36:21Z","timestamp":1519392981000},"page":"102-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Salmeterol undergoes enantioselective bronchopulmonary distribution with receptor localisation a likely determinant of duration of action"],"prefix":"10.1016","volume":"154","author":[{"given":"Glenn A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5558-3133","authenticated-orcid":false,"given":"Sharanne","family":"Raidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Robson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian K.","family":"Narkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-3132","authenticated-orcid":false,"given":"David S.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Haydn","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.02.048_bib0005","first-page":"A481","article-title":"The beta-adrenoceptor pharmacology of the enantiomers of salmeterol","volume":"149","author":"Nials","year":"1994","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jpba.2018.02.048_bib0010","article-title":"Development of new stereoisomeric drugs","author":"FDA","year":"1992","journal-title":"Guidances (Drugs)"},{"key":"10.1016\/j.jpba.2018.02.048_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-017-0631-1","article-title":"Long-acting beta2-agonists in asthma: enantioselective safety studies are needed","author":"Jacobson","year":"2018","journal-title":"Drug Saf."},{"issue":"17","key":"10.1016\/j.jpba.2018.02.048_bib0020","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","article-title":"Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma","volume":"327","author":"Cheung","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jpba.2018.02.048_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/pupt.1998.0110","article-title":"Effects of S-salbutamol on human isolated bronchus","volume":"11","author":"Templeton","year":"1998","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jpba.2018.02.048_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/pulp.1994.1043","article-title":"Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics","volume":"7","author":"Mazzoni","year":"1994","journal-title":"Pulm. Pharmacol."},{"issue":"8","key":"10.1016\/j.jpba.2018.02.048_bib0035","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/dta.2131","article-title":"Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control","volume":"9","author":"Jacobson","year":"2017","journal-title":"Drug Test Anal."},{"issue":"5","key":"10.1016\/j.jpba.2018.02.048_bib0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0700986","article-title":"The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol","volume":"120","author":"Nials","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.jpba.2018.02.048_bib0045","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.jpba.2018.02.048_bib0050","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjp.0707341","article-title":"Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1)","volume":"151","author":"Moaddel","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.jpba.2018.02.048_bib0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pupt.2011.08.002","article-title":"Rapid nongenomic actions of inhaled corticosteroids on long-acting beta(2)-agonist transport in the airway","volume":"24","author":"Horvath","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jpba.2018.02.048_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/evj.12586","article-title":"Equine asthma: an appropriate, translational and comprehendible terminology?","volume":"48","author":"Pirie","year":"2016","journal-title":"Equine Vet. J."},{"issue":"6","key":"10.1016\/j.jpba.2018.02.048_bib0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/evj.12680","article-title":"Pharmacological treatments in asthma-affected horses: a pair-wise and network meta-analysis","volume":"49","author":"Calzetta","year":"2017","journal-title":"Equine Vet. J."},{"issue":"7","key":"10.1016\/j.jpba.2018.02.048_bib0070","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/bcp.13228","article-title":"Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses","volume":"83","author":"Jacobson","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.02.048_bib0075","article-title":"Validation of analytical procedures: text and methodology","author":"ICH","year":"1994","journal-title":"Guideline IHT, Editor. Q2 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"issue":"1","key":"10.1016\/j.jpba.2018.02.048_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003088-200241010-00003","article-title":"Clinical pharmacokinetics of salmeterol","volume":"41","author":"Cazzola","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.jpba.2018.02.048_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pupt.2010.12.008","article-title":"Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi","volume":"24","author":"Matera","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jpba.2018.02.048_bib0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1067\/mai.2002.126661","article-title":"Bronchial hyperresponsiveness induced by chronic treatment with albuterol: role of sensory nerves","volume":"110","author":"Keir","year":"2002","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517323348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517323348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T01:48:21Z","timestamp":1549331301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517323348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":18,"alternative-id":["S0731708517323348"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.02.048","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salmeterol undergoes enantioselective bronchopulmonary distribution with receptor localisation a likely determinant of duration of action","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}